| Probable | Possible | TOTAL |
---|---|---|---|
Type of Surveillance | Â | ||
Passive surveillance | 25 | 18 | 43 |
Active surveillance | 9 | 15 | 24 |
Study District | Â | ||
Rufiji | 14 | 20 | 34 |
Kilombero/Ulanga | 20 | 13 | 33 |
Type of Drug Used | Â | ||
SP monotherapy | 29 | 24 | 53 |
AS monotherapy | 0 | 1 | 1 |
AS/SP combination | 5 | 8 | 13 |
TOTAL | 34 (51%) | 33 (49%) | 67 (100%) |